ISSN: 1946-6234

Journal Home

Science Translational Medicine Q1 Unclaimed

American Association for the Advancement of Science United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine It has an SJR impact factor of 5.5.

Science Translational Medicine focuses its scope in these topics and keywords: m, h, cell, n, il, f, j, therapy, immune, gene, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy: Non Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1)

Price

- €

Inmediate OA

- €

Embargoed OA

900 €

Non OA

Metrics

5.5

SJR Impact factor

242

H Index

370

Total Docs (Last Year)

1240

Total Docs (3 years)

22639

Total Refs

15329

Total Cites (3 years)

1121

Citable Docs (3 years)

12.32

Cites/Doc (2 years)

61.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
The Lancet Global Health Q1
Nature Reviews Disease Primers Q1

Compare this journals

Aims and Scope

Best articles by citations

Ovarian Cancer Going Viral

Spreading Aches

Peer-to-Peer Sharing Spurs Scientific Innovation

Nurturing the Impulse to Supersize

What's old is new again: Autologous stem cell transplant for AMD

Training Translators for Smart Drug Discovery

Stopping a Mutant Kinase in Its Tracks

Too Much of a Good Thing

Measuring thePlasmodium falciparumHRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis

Giving Tumors the Silent Treatment

Let There Be Light: Next-Generation Artificial Corneas

Genetic Polymorphisms: A Cornerstone of Translational Biobehavioral Research

SHOW MORE ARTICLES

Monitoring Methylation

Some Rozi for CF Too!

Retinal Stem Cells: Eye Know Where to Go

Science Translational Medicine Podcast: 7 April 2010

Statistical Challenges in the Evaluation of Treatments for Small Patient Populations

Fishermen and Farmers Share SNPs and Severe Fibrosis

Efficacy of Cetuximab in the Treatment of Menetrier's Disease

Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness

Moms and the Metabolic Syndrome

Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation

Playing Without Pain--Or Tumors

A BRCA3 Gene?